The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC)

Arndt Vogel, Thorsten Oliver Goetze, Guido Hausner, Michael Geissler, Gabriele Margareta Siegler, Ludwig Fischer von Weikersthal, Angelika M. R. Kestler, Matthias Kleiss, Tobias Mueller, Andreas Teufel, Jens Marquardt, Maria A. Gonzalez-Carmona, Daniel Wilhelm Mueller, Regina Eickhoff, Enrico N. de Toni, Oliver Waidmann, Salah-Eddin Al-Batran

Research output: Contribution to journalOriginal Articlepeer-review

3 Citations (Web of Science)
Original languageUndefined/Unknown
JournalJournal of Clinical Oncology
DOIs
Publication statusPublished - 2021

Cite this